Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107474795 ISBN 13: 9781107474796
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 44,72
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107474795 ISBN 13: 9781107474796
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. This book explores the relationship between politics, ethics and law in risk governance involving multi-valued human biological materials, such as blood. Series: Cambridge Bioethics and Law. Num Pages: 284 pages, 1 b/w illus. BIC Classification: LNTM; PSAD. Category: (P) Professional & Vocational. Dimension: 230 x 152 x 13. Weight in Grams: 412. . 2014. Paperback. . . . . Books ship from the US and Ireland.
Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107474795 ISBN 13: 9781107474796
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 63,81
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 284 pages. 8.90x5.90x0.70 inches. In Stock.
Sprache: Englisch
Verlag: Cambridge University Press, 2014
ISBN 10: 1107474795 ISBN 13: 9781107474796
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analysed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.